Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tara R Rheault

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of the American Chemical Society|March 21, 2002
Acyclic diastereoselection in prochiral radical addition to prochiral olefinsMukund P Sibi, Tara R Rheault, Sithamalli V Chandramouli, et al.
Bioorganic & Medicinal Chemistry Letters|July 3, 2010
Heteroaryl-linked 5-(1H-benzimidazol-1-yl)-2-thiophenecarboxamides: potent inhibitors of polo-like kinase 1 (PLK1) with improved drug-like propertiesTara R Rheault, Kelly H Donaldson, Jennifer G Badiang-Alberti, et al.
Plos One|July 12, 2013
Dabrafenib; preclinical characterization, increased efficacy when combined with trametinib, while BRAF/MEK tool combination reduced skin lesionsAlastair J King, Marc R Arnone, Maureen R Bleam, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2011
Development of potent B-RafV600E inhibitors containing an arylsulfonamide headgroupJohn C Stellwagen, George M Adjabeng, Marc R Arnone, et al.
Bioorganic & Medicinal Chemistry Letters|December 30, 2008
Thienopyrimidine-based dual EGFR/ErbB-2 inhibitorsTara R Rheault, Thomas R Caferro, Scott H Dickerson, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Dabrafenib: A Selective Inhibitor of Raf Kinases with Antitumor Activity against B-Raf-Driven TumorsTara R Rheault, John C Stellwagen, George M Adjabeng, et al.
Journal of Medicinal Chemistry|August 13, 2015
Discovery of 4-Amino-8-quinoline Carboxamides as Novel, Submicromolar Inhibitors of NAD-Hydrolyzing Enzyme CD38J David Becherer, Eric E Boros, Tiffany Y Carpenter, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2008
Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitorsKirk L Stevens, Krystal J Alligood, Jennifer G Badiang Alberti, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of the American Chemical Society|March 21, 2002
Acyclic diastereoselection in prochiral radical addition to prochiral olefinsMukund P Sibi, Tara R Rheault, Sithamalli V Chandramouli, et al.
Bioorganic & Medicinal Chemistry Letters|July 3, 2010
Heteroaryl-linked 5-(1H-benzimidazol-1-yl)-2-thiophenecarboxamides: potent inhibitors of polo-like kinase 1 (PLK1) with improved drug-like propertiesTara R Rheault, Kelly H Donaldson, Jennifer G Badiang-Alberti, et al.
Plos One|July 12, 2013
Dabrafenib; preclinical characterization, increased efficacy when combined with trametinib, while BRAF/MEK tool combination reduced skin lesionsAlastair J King, Marc R Arnone, Maureen R Bleam, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2011
Development of potent B-RafV600E inhibitors containing an arylsulfonamide headgroupJohn C Stellwagen, George M Adjabeng, Marc R Arnone, et al.
Bioorganic & Medicinal Chemistry Letters|December 30, 2008
Thienopyrimidine-based dual EGFR/ErbB-2 inhibitorsTara R Rheault, Thomas R Caferro, Scott H Dickerson, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Dabrafenib: A Selective Inhibitor of Raf Kinases with Antitumor Activity against B-Raf-Driven TumorsTara R Rheault, John C Stellwagen, George M Adjabeng, et al.
Journal of Medicinal Chemistry|August 13, 2015
Discovery of 4-Amino-8-quinoline Carboxamides as Novel, Submicromolar Inhibitors of NAD-Hydrolyzing Enzyme CD38J David Becherer, Eric E Boros, Tiffany Y Carpenter, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2008
Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitorsKirk L Stevens, Krystal J Alligood, Jennifer G Badiang Alberti, et al.
Pageof 1